| Ms Alisha Williams, OTR/L | |
|
9229 Arlington Blvd, Fairfax, VA 22031-2504 | |
| (703) 277-6611 | |
| Not Available |
| Full Name | Ms Alisha Williams |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 9229 Arlington Blvd, Fairfax, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215460092 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0119006274 (Virginia) | Primary |
| 225X00000X | Occupational Therapist | OT0100001037 (District Of Columbia) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Alisha Williams, OTR/L 9229 Arlington Blvd, Fairfax, VA 22031-2504 Ph: (703) 277-6611 | Ms Alisha Williams, OTR/L 9229 Arlington Blvd, Fairfax, VA 22031-2504 Ph: (703) 277-6611 |
News Archive
New analyses from the Global Anticoagulant Registry in the Field - Atrial Fibrillation (GARFIELD-AF) will be presented at ESC Congress 2015 to be held in London, United Kingdom, from August 29 to September 2, 2015.
Dr. Olivier Feron and his team from the University of Louvain Medical School in Brussels have turned the whole concept of targeting tumour blood vessels on its head. Instead of the conventional approach of trying to starve tumour cells of the blood supply they need to grow, they are doing the opposite – opening up the tumour blood supply to allow better access for cancer drugs and more effective radiotherapy.
A preliminary analysis of an ongoing study of more than 300 COVID-19 patients treated with convalescent plasma therapy at Houston Methodist suggests the treatment is safe and effective.
Using computer modeling, the Translational Genomics Research Institute and Scottsdale Healthcare have discovered lung cancer 'pathways' that could become targets for new drugs, according to a scientific paper published online today by the Journal of Thoracic Oncology.
Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology, highlighted the Phase III trial data presented on June 5 at the American Society of Clinical Oncology's 2010 Annual Meeting, comparing percutaneous hepatic perfusion with melphalan to the best alternative care for patients with hepatic metastases from ocular or cutaneous melanoma.
› Verified 5 days ago
Judy D. Feingold, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3900 Jermantown Rd Ste 250, Fairfax, VA 22030 Phone: 703-910-5006 Fax: 888-314-6706 | |
Alice Blair, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9685 Main St Ste B, Fairfax, VA 22031 Phone: 703-978-8400 Fax: 703-978-9898 | |
Sarah Tatlonghari, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 11240 Waples Mill Rd, Suite 202, Fairfax, VA 22030 Phone: 703-237-2219 | |
Carly Nassereh Ettefagh, MSOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8270 Willow Oaks Corporate Dr, Fairfax, VA 22031 Phone: 401-835-3265 | |
Samantha Hamlin, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8270 Willow Oaks Corporate Dr # 2120, Fairfax, VA 22031 Phone: 571-423-4864 | |
Jaclyn Rotier, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 12475 Lee Jackson Memorial Hwy, Fairfax, VA 22033 Phone: 408-439-4160 | |
Rebecca Learned Lambright, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 11240 Waples Mill Rd, Fairfax, VA 22030 Phone: 703-237-2219 Fax: 703-237-2729 |